Skip to content
Search

Latest Stories

Ashwin and Vijay playing is boost for Tamil Nadu in Ranji Trophy opener

Ignored for India's Twenty20 series against Australia, off-spinner Ravichandran Ashwin was today (03) named in the 15-member Tamil Nadu Ranji squad along with Test opener Murali Vijay for the season-opener against Andhra Pradesh, starting Friday (06).

The team, to be led by Abhinav Mukund, would miss the services of the experienced batsman-wicketkeeper Dinesh Karthik and all-rounder Vijay Shankar.


Karthik has been picked for the T20 series against Australia while Shankar features in the Board President's XI to face New Zealand.

The team includes exciting all-rounder Washington Sundar, who has impressed with his recent performances including in the Duleep Trophy final.

Baba Indrajith, who scored a double ton on his Duleep Trophy debut, would be Mukund's deputy.

The team also features aggressive wicketkeeper-batsman N Jagadeesan and another gloveman in R Rohith, who shone in the recent Tamil Nadu Premier League (TNPL).

In the absence of T Natarajan and Aswin Crist due to fitness issues, the pace attack would be led by K Vignesh, who did well in his debut season with 30-plus wickets as Tamil Nadu made the semifinals.

L Vignesh and V Lakshman are the other fast bowlers named in the squad.

With the wicket at the M A Chidambaram Stadium likely to assist the spinners, the selectors have picked three specialists apart from Ashwin and Washington Sundar.

"It is a good team. We have a mix of experience and youth. The availability of Ashwin and Vijay is certain to bolster the squad," said chairman of selectors Sridharan Sharath.

Left-arm spinner R Sai Kishore and Lakshman, who had done well in the local league, have also been picked.

"Not having Vijay Shankar (limited overs captain) is a big miss. But we have Ashwin, Washington Sundar and other all-rounders in the squad," Sharath said.

Squad: Abhinav Mukund (C), Baba Indrajith (VC), M Vijay, M Kaushik Gandhi, N Jagadeesan (WK), Baba Aparajith, MS Washington Sundar, Rahil S Shah, K Vignesh, R Ashwin, L Vignesh, R Sai Kishore, V Lakshman, R Rohith (WK) and Malolan Rangarajan.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less